Results 241 to 250 of about 222,974 (348)

Randomized clinical trial evaluating kinetic benefits of desensitizing agents: Magnitude, onset, and stability of relief

Journal of Periodontology, EarlyView.
Abstract Background Dentin hypersensitivity (DH) is common, particularly among periodontal patients. This trial evaluated magnitude of desensitizing benefit, onset of action, and complete relief of three dentifrices with distinct desensitizing technologies.
Aaron R. Biesbrock, Tao He, Yuanshu Zou, Julie M. Grender, Pejmon Amini, Paul A. Sagel, Andrew Groth, Malgorzata Klukowska   +7 more
wiley   +1 more source

Allergy to Lipid Transfer Protein or Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs? [PDF]

Magdalena Rydzyńska, Kinga Lis, Zbigniew Bartuzi, Tomasz Rosada, Magdalena Grześk-Kaczyńska, Natalia Ukleja-Sokołowska   +5 more
openalex   +1 more source

Efficacy of a Standardized Premedication and Therapeutic Drug Monitoring Protocol for Pegaspargase to Prevent Hypersensitivity Reactions

, 2022
Kyle J. Babcock, Amy Kinnunen, Tosha A. Egelund, John S. Ng, Michael Joyce   +4 more
openalex   +2 more sources

Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Due to Multiple Anti-Epileptic Drug Hypersensitivity. [PDF]

Cureus
Ajon ARS, Camara PTA.
europepmc   +1 more source

Fulminant Type 1 Diabetes Mellitus Associated With Drug Hypersensitivity and Epstein-Barr Virus Infection: A Case Report. [PDF]

Front Pharmacol, 2022
Chen XY, Wang C, Chen S, Tian M, Wang X, Zhang L.   +5 more
europepmc   +1 more source

Severe allergic reaction to ustekinumab reinitiation in a pediatric patient with Crohn's disease: A case report

JPGN Reports, EarlyView.
Abstract Ustekinumab (UST) is a monoclonal antibody used in the management of moderate to severe inflammatory bowel disease. While generally well‐tolerated, serious adverse reactions, including hypersensitivity and anaphylaxis, have been documented, specifical following the initial intravenous (IV) dose.
Kennedy Sparling, Shauna Schroeder, Brad Pasternak   +2 more
wiley   +1 more source

Modification Of Basophil Activation Test For Detecting Drug Hypersensitivity [PDF]

, 2008
Michiko Haida, Kaori Koyanagi, Mizuki Shinoda, Y. Noma, A. Hashiguchi, Hiroyuki Hirai, Keiko Nagata   +6 more
openalex   +1 more source

Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions. [PDF]

Heliyon
Molatefi R, Talebi S, Samei A, Roshanravan N, Manshouri S, Hashemi B, Ghobadi Dana V, Mosharkesh E, Bahar MA, Khajoei S, Seif F.   +10 more
europepmc   +1 more source

Dupilumab as an effective therapy for eosinophilic esophagitis in pediatric patients weighing less than 15 kilograms

JPGN Reports, EarlyView.
Abstract Objectives Eosinophilic esophagitis (EoE) is a type 2 cytokine‐mediated chronic inflammatory condition leading to esophageal dysfunction. Dupilumab blocks IL‐4 and IL‐13 signaling, which are key inflammatory mediators in EoE and other allergic disorders.
Sindhura Kasturi, Tanaz Danialifar, Thirumazhisai Gunasekaran, Nick Shillingford, Paul Zamiara, Vrinda Bhardwaj, Melinda Braskett   +6 more
wiley   +1 more source

Drug hypersensitivity: We need to do more [PDF]

, 2017
Werner J. Pichler, Daniel Yerly
openalex   +1 more source